| 臺大學術典藏 |
2021-08-11T03:46:47Z |
Efficacy, safety, and potential biomarkers of thalidomide plus metronomic chemotherapy for advanced hepatocellular carcinoma
|
Shao Y.-Y.; ZHONG-ZHE LIN; Hsu C.; Lee K.-D.; Hsiao C.-H.; Lu Y.-S.; Huang C.-C.; Shen Y.-C.; Hsu C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-08-11T03:46:46Z |
Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma
|
Shau W.-Y.; Shao Y.-Y.; Yeh Y.-C.; ZHONG-ZHE LIN; Kuo R.; Hsu C.-H.; Hsu C.; Cheng A.-L.; Lai M.-S. |
| 臺大學術典藏 |
2021-08-11T03:46:46Z |
Factors impacting prognosis prediction in BCLC stage C and Child-Pugh Class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapy
|
ZHONG-ZHE LIN; Hsu C.; Hu F.-C.; Shao Y.-Y.; Chang D.-Y.; Yang C.-H.; Hong R.-L.; Hsu C.-H.; Chengb A.-L. |
| 臺大學術典藏 |
2021-08-11T03:46:45Z |
Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems
|
Shao Y.-Y.; Lu L.-C.; ZHONG-ZHE LIN; Hsu C.; Shen Y.-C.; Hsu C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-08-11T03:46:43Z |
A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti-angiogenic therapy
|
Shao Y.-Y.; Liang P.-C.; Wu Y.-M.; Huang C.-C.; Huang K.-W.; Cheng J.C.; Hsu C.-H.; Hsu C.; Cheng A.-L.; ZHONG-ZHE LIN |
| 臺大學術典藏 |
2021-08-11T03:46:43Z |
Hospital volume of percutaneous radiofrequency ablation is closely associated with treatment outcomes for patients with hepatocellular carcinoma
|
Lu L.-C.; Shao Y.-Y.; Kuo R.N.C.; ZHONG-ZHE LIN; Yeh Y.-C.; Shau W.-Y.; Hsu C.-H.; Cheng A.-L.; Lai M.-S. |
| 臺大學術典藏 |
2021-08-11T03:46:43Z |
Radiofrequency ablation is superior to ethanol injection in early-stage hepatocellular carcinoma irrespective of tumor size
|
ZHONG-ZHE LIN; Shau W.-Y.; Hsu C.; Shao Y.-Y.; Yeh Y.-C.; Kuo R.N.-C.; Hsu C.-H.; Yang J.C.-H.; Cheng A.-L.; Lai M.-S. |
| 臺大學術典藏 |
2021-08-11T03:46:40Z |
Statin Use Is Associated With Improved Prognosis of Colorectal Cancer in Taiwan
|
Shao Y.-Y.; Hsu C.-H.; Yeh K.-H.; Chen H.-M.; Yeh Y.-C.; Lai C.-L.; ZHONG-ZHE LIN; Cheng A.-L.; Lai M.-S. |
| 臺大學術典藏 |
2021-08-11T03:46:39Z |
Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)
|
Abou-Alfa G.K.; Yen C.-J.; Hsu C.-H.; O��Donoghue J.; Beylergil V.; Ruan S.; Pandit-Taskar N.; Gansukh B.; Lyashchenko S.K.; Ma J.; Wan P.; Shao Y.-Y.; ZHONG-ZHE LIN; Frenette C.; O��Neil B.; Schwartz L.; Smith-Jones P.M.; Ohtomo T.; Tanaka T.; Morikawa H.; Maki Y.; Ohishi N.; Chen Y.-C.; Agajanov T.; Boisserie F.; Di Laurenzio L.; Lee R.; Larson S.M.; Cheng A.-L.; Carrasquilo J.A. |
| 臺大學術典藏 |
2021-08-11T03:46:38Z |
Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy
|
Shao Y.-Y.; Chen B.-B.; Ou D.-L.; ZHONG-ZHE LIN; Hsu C.-H.; Wang M.-J.; Cheng A.-L.; Hsu C. |
| 臺大學術典藏 |
2021-08-11T03:46:37Z |
Considerations of heterogeneity in clinical trials for hepatocellular carcinoma
|
Liu T.-H.; Shao Y.-Y.; Lu L.-C.; Shen Y.-C.; Hsu C.; ZHONG-ZHE LIN; Hsu C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-08-11T03:46:36Z |
Early alpha-foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma
|
Shao Y.-Y.; Liu T.-H.; Hsu C.; Lu L.-C.; Shen Y.-C.; ZHONG-ZHE LIN; Cheng A.-L.; Hsu C.-H. |
| 臺大學術典藏 |
2021-08-11T03:46:34Z |
A Multicenter Phase II Study of Second-Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First-Line Sorafenib Monotherapy
|
ZHONG-ZHE LIN; Chen B.-B.; Hung Y.-P.; Huang P.-H.; Shen Y.-C.; Shao Y.-Y.; Hsu C.-H.; Cheng A.-L.; Lee R.-C.; Chao Y.; Hsu C. |
| 臺大學術典藏 |
2021-08-11T03:46:33Z |
Dynamic contrast-enhanced and intravoxel incoherent motion mri biomarkers are correlated to survival outcome in advanced hepatocellular carcinoma
|
Chen B.-B.; Shao Y.-Y.; ZHONG-ZHE LIN; Hsu C.-H.; Cheng A.-L.; Hsu C.; Liang P.-C.; Shih T.T.-F. |
| 臺大學術典藏 |
2021-08-10T03:53:07Z |
Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not participate in clinical trials
|
SHIH-HUNG YANG; Kuo Y.-H.; Tien Y.-W.; Hsu C.; Hsu C.-H.; Kuo S.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-08-10T03:53:05Z |
Nuclear expression of glioma-associated oncogene homolog 1 and nuclear factor-�eb is associated with a poor prognosis of pancreatic cancer
|
SHIH-HUNG YANG; Hsu C.-H.; Lee J.-C.; Tien Y.-W.; Kuo S.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-08-10T03:53:04Z |
Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer
|
SHIH-HUNG YANG; Kuo T.-C.; Wu H.; Guo J.-C.; Hsu C.; Hsu C.-H.; Tien Y.-W.; Yeh K.-H.; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2021-08-03T07:10:54Z |
Potential of circulating immune cells as biomarkers of nivolumab treatment efficacy for advanced hepatocellular carcinoma
|
Hung Y.-P.; YU-YUN SHAO; Lee J.-M.; Hsu C.; Hsu C.-H.; Yang M.-H.; Chao Y. |
| 臺大學術典藏 |
2021-08-03T07:10:53Z |
Solving the deficit of cancer pain management skills by education programs
|
YU-YUN SHAO; Lin W.-Y.; Lin C.-P.; Lu L.-C.; Hsu C.-H. |
| 臺大學術典藏 |
2021-08-03T07:10:52Z |
An Underdiagnosed Hypothyroidism and Its Clinical Significance in Patients with Advanced Hepatocellular Carcinoma
|
YU-YUN SHAO; Cheng A.-L.; Hsu C.-H. |
| 臺大學術典藏 |
2021-08-03T07:10:52Z |
The unique characteristic in peripheral immune cells in patients with advanced hepatocellular carcinoma
|
Hung Y.-P.; YU-YUN SHAO; Hsu C.; Hsu C.-H.; Lee J.-M.; Yang M.-H.; Chao Y. |
| 臺大學術典藏 |
2021-07-26T10:04:13Z |
Erratum: Crystal structure of α?'Galactosidase from thermus thermophilus: Insight into hexamer assembly and substrate specificity (Journal of Agricultural and Food Chemistry (2020) 68:22 (6161-6169) DOI: 10.1021/acs.jafc.0c00871)
|
Chen S.-C;Wu S.-P;Chang Y.-Y;Hwang T.-S;Lee T.-H;Hsu C.-H.; Chen S.-C; Wu S.-P; Chang Y.-Y; Hwang T.-S; Lee T.-H; Hsu C.-H.; TZONG-HUEI LEE |
| 臺大學術典藏 |
2021-07-26T10:01:58Z |
Curcumin and freshwater clam extracts alleviate the progression of osteoarthritis by reducing synovial inflammation and allowing cartilage regeneration
|
Ke C.-H;Hsu C.-H;Lin Y.-L;Huang W.-H;Weng H.-P;Ke Y.-T;Lin C.-S.; Ke C.-H; Hsu C.-H; Lin Y.-L; Huang W.-H; Weng H.-P; Ke Y.-T; Lin C.-S.; WEI-HSIANG HUANG |
| 臺大學術典藏 |
2021-07-26T10:01:53Z |
Kynurenine 3-monooxygenase (KMO), and signal transducer and activator of transcription 3 (STAT3) expression is involved in tumour proliferation and predicts poor survival in canine melanoma
|
Liu I.-L;Chung T.-F;Huang W.-H;Hsu C.-H;Liu C.-C;Chiu Y.-H;Huang K.-C;Liao A.T.-C;Lin C.-S.; Liu I.-L; Chung T.-F; Huang W.-H; Hsu C.-H; Liu C.-C; Chiu Y.-H; Huang K.-C; Liao A.T.-C; Lin C.-S.; TAI-CHING LIAO |
| 臺大學術典藏 |
2021-07-26T10:01:53Z |
Inhibiting autophagy potentiates the antitumor efficacy of Euphorbia royleana for canine mammary gland tumors
|
Huang Y.-Y;Chen C.-H;Hsu C.-H;Kuo T.-Y;Liu C.-C;Liao A.T.-C;Liao A.T.-C;Lin C.-S;Lin C.-S.; Huang Y.-Y; Chen C.-H; Hsu C.-H; Kuo T.-Y; Liu C.-C; Liao A.T.-C; Liao A.T.-C; Lin C.-S; Lin C.-S.; TAI-CHING LIAO |
| 臺大學術典藏 |
2021-07-26T10:01:45Z |
Genome-wide DNA methylation analysis using MethylCap-seq in canine high-grade B-cell lymphoma
|
Hsu C.-H;Tomiyasu H;Lee J.-J;Tung C.-W;Liao C.-H;Chuang C.-H;Huang L.-Y;Liao K.-W;Chou C.-H;Liao A.T.C;Lin C.-S.; Hsu C.-H; CHUNG-HSI CHOU et al. |
| 臺大學術典藏 |
2021-07-26T09:44:18Z |
Atomic layer deposited single-crystal hexagonal perovskite YAlO3 epitaxially on GaAs(111)A
|
Young L.B;Cheng C.-K;Lu G.-J;Lin K.-Y;Lin Y.-H;Wan H.-W;Li M.-Y;Cai R.-F;Lo S.-C;Hsu C.-H;Kwo J;Hong M.; Young L.B; CHIA-KUEN CHENG et al. |
| 臺大學術典藏 |
2021-07-26T09:44:17Z |
Low-Temperature-Grown Single-Crystal Si Epitaxially on Ge, Followed by Direct Deposition of High-κ Dielectrics-Attainment of Low Interfacial Traps and Highly Reliable Ge MOS
|
Wan H.-W;Hong Y.-J;Cheng Y.-T;Cheng C.-K;Hsu C.-H;Wu C.-T;Pi T.-W;Kwo J;Hong M.; Wan H.-W; Hong Y.-J; Cheng Y.-T; Cheng C.-K; Hsu C.-H; Wu C.-T; Pi T.-W; Kwo J; Hong M.; CHIA-KUEN CHENG |
| 臺大學術典藏 |
2021-07-26T09:44:17Z |
GaAs metal-oxide-semiconductor push with molecular beam epitaxy Y2O3 – In comparison with atomic layer deposited Al2O3
|
Wan H.W;Lin K.Y;Cheng C.K;Su Y.K;Lee W.C;Hsu C.H;Pi T.W;Kwo J;Hong M.; Wan H.W; Lin K.Y; Cheng C.K; Su Y.K; Lee W.C; Hsu C.H; Pi T.W; Kwo J; Hong M.; CHIA-KUEN CHENG |
| 臺大學術典藏 |
2021-07-26T09:44:16Z |
Van der Waals epitaxy of topological insulator Bi2Se3 on single layer transition metal dichalcogenide MoS2
|
Chen K.H.M;Lin H.Y;Yang S.R;Cheng C.K;Zhang X.Q;Cheng C.M;Lee S.F;Hsu C.H;Lee Y.H;Hong M;Kwo J.; Chen K.H.M; CHIA-KUEN CHENG et al. |
| 臺大學術典藏 |
2021-07-26T09:43:56Z |
Erratum: Crystal structure of α?'Galactosidase from thermus thermophilus: Insight into hexamer assembly and substrate specificity (Journal of Agricultural and Food Chemistry (2020) 68:22 (6161-6169) DOI: 10.1021/acs.jafc.0c00871)
|
Chen S.-C;Wu S.-P;Chang Y.-Y;Hwang T.-S;Lee T.-H;Hsu C.-H.; Chen S.-C; Wu S.-P; Chang Y.-Y; Hwang T.-S; Lee T.-H; Hsu C.-H.; CHUN-HUA HSU |
| 臺大學術典藏 |
2021-07-26T09:43:56Z |
Elucidating the tunability of binding behavior for the MERS-CoV macro domain with NAD metabolites
|
Lin M.-H;Cho C.-C;Chiu Y.-C;Chien C.-Y;Huang Y.-P;Chang C.-F;Hsu C.-H.; Lin M.-H; Cho C.-C; Chiu Y.-C; Chien C.-Y; Huang Y.-P; Chang C.-F; Hsu C.-H.; CHUN-HUA HSU |
| 臺大學術典藏 |
2021-07-26T09:43:55Z |
Structural basis for promoter DNA recognition by the response regulator OmpR
|
Sadotra S;Lou Y.-C;Tang H.-C;Chiu Y.-C;Hsu C.-H;Chen C.; Sadotra S; Lou Y.-C; Tang H.-C; Chiu Y.-C; Hsu C.-H; Chen C.; CHUN-HUA HSU |
| 臺大學術典藏 |
2021-07-26T09:43:55Z |
NMR assignments of the macro domain from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
|
Lin M.-H;Huang Y.-P;Chang C.-F;Hsu C.-H.; Lin M.-H; Huang Y.-P; Chang C.-F; Hsu C.-H.; CHUN-HUA HSU |
| 臺大學術典藏 |
2021-07-26T09:43:55Z |
Molecular elucidation of a urate oxidase from deinococcus radiodurans for hyperuricemia and gout therapy
|
Chiu Y.-C;Hsu T.-S;Huang C.-Y;Hsu C.-H.; Chiu Y.-C; Hsu T.-S; Huang C.-Y; Hsu C.-H.; CHUN-HUA HSU |
| 臺大學術典藏 |
2021-07-23T07:49:44Z |
Right or left? Side selection for a totally implantable vascular access device: A randomised observational study
|
WEN-YING LIN; Lin C.-P.; Hsu C.-H.; Lee Y.-H.; Lin Y.-T.; Hsu M.-C.; Shao Y.-Y. |
| 臺大學術典藏 |
2021-07-23T07:49:43Z |
Solving the deficit of cancer pain management skills by education programs
|
Shao Y.-Y.; WEN-YING LIN; Lin C.-P.; Lu L.-C.; Hsu C.-H. |
| 臺大學術典藏 |
2021-07-13T06:04:29Z |
A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors
|
LEE JIH-HSIANG; Chen T.W.-W.; Hsu C.-H.; Yen Y.-H.; Yang J.C.-H.; Cheng A.-L.; Sasaki S.-I.; Chiu L.Y.; Sugihara M.; Ishizuka T.; Oguma T.; Tajima N.; Lin C.-C. |
| 臺大學術典藏 |
2021-07-13T06:04:28Z |
Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours
|
de Bono J.; Lin C.-C.; Chen L.-T.; Corral J.; Michalarea V.; Rihawi K.; Ong M.; LEE JIH-HSIANG; Hsu C.-H.; Yang J.C.-H.; Shiah H.-S.; Yen C.-J.; Anthoney A.; Jove M.; Buschke S.; Fuertig R.; Schmid U.; Goeldner R.-G.; Strelkowa N.; Huang D.C.-L.; Bogenrieder T.; Twelves C.; Cheng A.-L. |
| 臺大學術典藏 |
2021-07-12T08:46:25Z |
�]-Catenin (CTNNB1) mutations are not associated with prognosis in advanced hepatocellular carcinoma
|
Lu L.-C.; Shao Y.-Y.; Lee Y.-H.; Hsieh M.-S.; Hsiao C.-H.; Lin H.-H.; HSIANG-FONG KAO; Ma Y.-Y.; Yen F.-C.; Cheng A.-L.; Hsu C.-H. |
| 臺大學術典藏 |
2021-07-07T05:13:13Z |
Synthesis of galanthamine analogs as acetylcholinesterase inhibitors via intramolecular heck cvclization
|
Liang P.-H.; LING-WEI HSIN; Pong S.-L.; Hsu C.-H.; Cheng C.-Y. |
| 臺大學術典藏 |
2021-07-07T05:13:11Z |
Stereoselective synthesis of morphine fragments trans- and cis-octahydro-1H-benzo[4,5]furo[3,2-e]isoquinolines
|
LING-WEI HSIN; Chang L.-T.; Chen C.-W.; Hsu C.-H.; Chen H.-W. |
| 臺大學術典藏 |
2021-07-07T03:23:27Z |
Prolonged and enhanced suppression of thymidylate synthase by weekly 24-h infusion of high-dose 5-fluorouracil
|
Yeh K.-H.; Yeh S.-H.; Hsu C.-H.; TONG-MEI WANG; Ma I.-F.; Cheng A.-L. |
| 臺大學術典藏 |
2021-07-06T02:37:31Z |
Association between prior use of anti-diabetic medication and breast cancer stage at diagnosis
|
Fahim S.M.; Hsu C.-H.; FANG-JU LIN; Qian J.; Chou C. |
| 臺大學術典藏 |
2021-07-03T03:35:40Z |
Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma
|
Cheng A.-L.; Hsiung C.A.; Su I.-J.; PEI-JER CHEN; Chang M.-C.; Tsao C.-J.; Kao W.-Y.; Uen W.-C.; Hsu C.-H.; Tien H.-F.; Chao T.-Y.; Chen L.-T.; Whang-Peng J. |
| 臺大學術典藏 |
2021-07-03T03:35:33Z |
Doxorubicin activates hepatitis B virus (HBV) replication in HBV-harboring hepatoblastoma cells. A possible novel mechanism of HBV reactivation in HBV carriers receiving systemic chemotherapy
|
Hsu C.-H.; Hsu H.-C.; Chen H.-L.; Gao M.; Yeh P.-Y.; PEI-JER CHEN; Cheng A.-L. |
| 臺大學術典藏 |
2021-07-03T03:35:21Z |
Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients
|
Su W.-P.; Wen C.-C.; Hsiung C.A.; Su I.-J.; Cheng A.-L.; Chang M.-C.; Tsao C.-J.; Kao W.-Y.; Uen W.-C.; Hsu C.-H.; Lu Y.-S.; Tien H.-F.; Chao T.-Y.; Chen L.-T.; Whang-Peng J.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-07-03T03:34:50Z |
Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway
|
Chen K.-F.; Yeh P.-Y.; Hsu C.; Hsu C.-H.; Lu Y.-S.; Hsieh H.-P.; PEI-JER CHEN; Cheng A.-L. |
| 臺大學術典藏 |
2021-07-03T03:34:48Z |
Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma
|
Hsu C.-H.; Shen Y.-C.; Lin Z.-Z.; PEI-JER CHEN; Shao Y.-Y.; Ding Y.-H.; Hsu C.; Cheng A.-L. |
| 臺大學術典藏 |
2021-07-03T03:34:46Z |
Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma
|
Hsu C.-H.; Yang T.-S.; Hsu C.; Toh H.C.; Epstein R.J.; Hsiao L.-T.; PEI-JER CHEN; Lin Z.-Z.; Chao T.-Y.; Cheng A.-L. |
